M.H. Cullen - Concepedia

Author

M.H. Cullen

Queen Elizabeth Hospital Birmingham ORCID

Also Known As

G M Mead, M Cullen, M H Cullen, M. Cullen, M. H. CULLEN, M. H. Cullen, M.H Cullen, M.H. Cullen, MH Cullen, Maikki Cullen

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Queen Elizabeth Hospital Birmingham St Bartholomew's Hospital Nottingham City Hospital The Christie Hospital University of Birmingham

About

M.H. Cullen is an author at Queen Elizabeth Hospital Birmingham specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	1.3K
2	Health Sciences	7	7	299
3	Immunology	4	4	134
4	Cell Biology	2	2	24
5	Medical Laboratory Science	1	1	10

M.H. Cullen

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life M.H. Cullen, Lucinda Billingham, C.M. Woodroffe, Journal of Clinical Oncology	1999	448
Management of febrile neutropenia: ESMO Clinical Practice Guidelines Julien de Naurois, Igor Novitzky‐Basso, M. John Gill, Annals of Oncology MedicineClinical ManagementFebrile Neutropenia	2010	435
Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial Sophie D. Fosså, A. Horwich, JM Russell, Journal of Clinical Oncology	1999	385
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study. Stan B. Kaye, Graham M. Mead, Sophie D. Fosså, Journal of Clinical Oncology	1998	184
Histological transformation of non-hodgkin's lymphoma.A prospective study M.H. Cullen, Tim Lister, Roger Brearley, Cancer	1979	170
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. Tim Lister, M.H. Cullen, M. E. J. Beard, BMJ	1978	156
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours Sophie D. Fosså, Sally Stenning, A. Gerl, British Journal of Cancer	1999	148
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom. Sophie D. Fosså, Stuart Kaye, Graham M. Mead, Journal of Clinical Oncology	1998	145
PREVENTION OF EFFECTS OF ALCOHOL INTOXICATION BY NALOXONE William Jeffcoate, M.H. Cullen, M. Herbert, The Lancet Substance AbuseSubstance UseAddictionMedicineAddiction Medicine	1979	130
Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare M.H. Cullen, RameshC. Joshi, A.D. Chetiyawardana, British Journal of Cancer MedicinePharmacologyPathologyBronchial NeoplasmAnti-cancer Agent	1988	124

Page 1